|
| 1 | DIATRIZOATE MEGLUMINE - BIDDER SHOULD QUOTE FOR ALL STRENGTHS, TECHNICALLY SHORTLISTED INNOVATORS/ORIGINALS , L1 & L2 WILL BE SELECTED BASED ON CONSOLIDATED RESULTS. |
| 2 | DIATRIZOATE MEGLUMINE 65 % W/V |
| 3 | DIATRIZOATE MEGLUMINE 65 % W/V |
| 4 | DIATRIZOATE MEGLUMINE 76 % W/V |
| 5 | DIATRIZOATE MEGLUMINE 76 % W/V |
| 6 | GADOBENATE DIMEGLUMINE (BIDDER SHOULD QUOTE FOR ALL STRENGTHS, TECHNICALLY SHORTLISTED INNOVATORS/ORIGINALS , L1 & L2 WILL BE SELECTED BASED ON CONSOLIDATED RESULTS) |
| 7 | GADOBENATE DIMEGLUMINE 469 MG/ML |
| 8 | GADOBENATE DIMEGLUMINE 529 MG/ML |
| 9 | GADODIAMIDE (BIDDER SHOULD QUOTE FOR ALL STRENGTHS, TECHNICALLY SHORTLISTED INNOVATORS/ORIGINALS , L1 & L2 WILL BE SELECTED BASED ON CONSOLIDATED RESULTS) |
| 10 | GADODIAMIDE 0.5 MMOL/ML |
| 11 | GADODIAMIDE 0.5 MMOL/ML |
| 12 | GADOTERIDOL (BIDDER SHOULD QUOTE FOR ALL STRENGTHS, TECHNICALLY SHORTLISTED INNOVATORS/ORIGINALS , L1 & L2 WILL BE SELECTED BASED ON CONSOLIDATED RESULTS) |
| 13 | GADOTERIDOL |
| 14 | GADOTERIDOL |
| 15 | IODIXANOL (BIDDER SHOULD QUOTE FOR ALL STRENGTHS, TECHNICALLY SHORTLISTED INNOVATORS/ORIGINALS , L1 & L2 WILL BE SELECTED BASED ON CONSOLIDATED RESULTS) |
| 16 | IODIXANOL 270 MG I/ML |
| 17 | IODIXANOL 270 MG I/ML |
| 18 | IODIXANOL 320 MG I/ML |
| 19 | IODIXANOL 320 MG I/ML |
| 20 | IOHEXOL (BIDDER SHOULD QUOTE FOR ALL STRENGTHS, TECHNICALLY SHORTLISTED INNOVATORS/ORIGINALS , L1 & L2 WILL BE SELECTED BASED ON CONSOLIDATED RESULTS) |
| 21 | IOHEXOL / Non Ionic Contrast Media 300 MGI/ML |
| 22 | IOHEXOL / Non Ionic Contrast Media 300 MGI/ML |
| 23 | IOHEXOL / Non Ionic Contrast Media 300 MGI/ML |
| 24 | IOHEXOL / Non Ionic Contrast Media 350 MGI/ML |
| 25 | IOHEXOL / Non Ionic Contrast Media 350 MGI/ML |
| 26 | IOHEXOL / Non Ionic Contrast Media 350 MGI/ML |
| 27 | IOHEXOL / Non Ionic Contrast Media 350 MGI/ML |
| 28 | IOPROMIDE (BIDDER SHOULD QUOTE FOR ALL STRENGTHS, TECHNICALLY SHORTLISTED INNOVATORS/ORIGINALS , L1 & L2 WILL BE SELECTED BASED ON CONSOLIDATED RESULTS) |
| 29 | IOPROMIDE 300 MG I/ML |
| 30 | IOPROMIDE 300 MG I/ML |
| 31 | IOPROMIDE 350 MG I/ML |
| 32 | IOPROMIDE 370 MG I/ML |
| 33 | IOPROMIDE 370 MG I/ML |
| 34 | IOMEPROL (BIDDER SHOULD QUOTE FOR ALL STRENGTHS, TECHNICALLY SHORTLISTED INNOVATORS/ORIGINALS , L1 & L2 WILL BE SELECTED BASED ON CONSOLIDATED RESULTS) |
| 35 | IOMEPROL 300 MG I/ML |
| 36 | IOMEPROL 300 MG I/ML |
| 37 | METHYLENE BLUE (BIDDER SHOULD QUOTE FOR ALL STRENGTHS, TECHNICALLY SHORTLISTED INNOVATORS/ORIGINALS , L1 & L2 WILL BE SELECTED BASED ON CONSOLIDATED RESULTS) |
| 38 | METHYLENE BLUE 10 MG/ML |
| 39 | METHYLENE BLUE 10 MG/ML |
| 40 | METHYLENE BLUE STANDARD SOLUTION |
| 41 | NAME OF THE ITEMS |
| 42 | GADOBUTROL 1.0 MMOL/ML |
| 43 | IOBITRIDOL 350 MG |
| 44 | INDOCYANINE GREEN DYE |
| 45 | LIPIDOL(IODINE) 480 MG/MILLI AMPOULE |
| 46 | SULPHUR HEXAFLUORIDE MICROBUBBLE 45 MCG/ML Please Enable Macros to View BoQ information |
